Skip to content

Colorado · Nonprofit

POLITE TUMOR INC

POLITE TUMOR INC (Colorado) receives grants from 13 organizations whose IRS filings report $595,563 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($210,200). 9 of them have funded it in more than one year, and 96% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.

Revenue FY2024
$372k
Funders on record
13
Grants received
$596k
Net assets
$575k
9/13 repeat funderspeak grant-dependency 66%
01What it does

What Polite Tumor Inc does

Mission

Polite tumor's mission is to provide financial assistance to young adults under 40 who have been diagnosed with breast cancer. When financial assistance comes with strings attached, the message is "we know what you need more than you know what you need." polite tumor challenges that model. What we know is that cancer is expensive, that every person's needs are different, and that no one can foresee the financial obstacles that will be thrown their way. We're giving this community the opportunity to look beyond their diagnosis and their treatment, we're providing the freedom to heal however they define it.

As stated on its FY2024 Form 990.

Program

  1. To alleviate the financial impact on women diagnosed at an unexpectedly young age.

    $275,000 spentof which $275,000 as grants
    100% of program spending

The program described on its FY2024 Form 990. Program spending in total: $275,000.

02The organization over time

The organization over time

Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.

100 = 20172017 Revenue 100 ($62k) Expenses 0 ($0) Net assets 100 ($62k)2018 Revenue 275 ($171k) Expenses 100 ($32k) Net assets 324 ($202k)2019 Revenue 192 ($120k) Expenses 526 ($166k) Net assets 250 ($155k)2020 Revenue 252 ($157k) Expenses 303 ($96k) Net assets 348 ($217k)2021 Revenue 268 ($167k) Expenses 233 ($73k) Net assets 498 ($310k)2022 Revenue 433 ($269k) Expenses 481 ($152k) Net assets 687 ($427k)2023 Revenue 433 ($269k) Expenses 687 ($217k) Net assets 771 ($480k)2024 Revenue 597 ($372k) Expenses 877 ($277k) Net assets 924 ($575k)
'17'18'19'20'21'22'23'24
Revenue (597)Expenses (877)Net assets (924)Peer revenue range

Balance sheet

Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2017 to 2018, from $62k to $202k (+224%).

$62k
$202k
$155k
$217k
$310k
$427k
$480k
$575k
'17'18'19'20'21'22'23'24
Total assetsTotal liabilities

How it's funded, over time

Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.

2017
2018
2019
2020
2021
2022
2023
2024
ContributionsProgram revenueInvestmentOther

65% of POLITE TUMOR INC’s revenue is contributions — about as donation-reliant as the typical peer (83% for the typical peer).

This organization
Typical peer · 14,932 orgs

Surplus & reserves

Operating surplus or deficit each year, and months of liquidity in hand. 1 of the last 8 reported years ran a deficit.

$62k
’17
$139k
’18
−$46k
’19
$61k
’20
$93k
’21
$118k
’22
$52k
’23
$95k
’24
25
months of
reserve

Leadership and staff

The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.

Chief executive

Elissa Brown

CEO/board chair

As listed on its FY2024 Form 990.

202220232024
Listed553
Joined·+0+0
No longer listed·02
03Who funds it

Who funds it, year by year

2019 → 2023: the base broadened from 2 funders to 6 funders, grant income fell $79k → $78k.

7 of 13 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 96% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.

From the IRS filings of POLITE TUMOR INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How concentrated its funding is

POLITE TUMOR INC leans on a few funders — its largest provides 35% of grant income and the top three 84%; half comes from just 2 funders.

the vertical line marks half of all grant income — 2 funders to its left

96% of the income these shares are computed over arrives through pass-through sponsors or from payers whose filings do not say what kind of payment it is. Concentration is still measured over all of it, because the money is real; what it does not support is a claim about how many institutions have chosen to fund POLITE TUMOR INC.

35%
largest funder
84%
top three
~4
effective funders

Largest funder’s share by year: 2019 99% · 2020 75% · 2021 45% · 2022 37% · 2023 51% — diversifying over time.

“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

How long its funders stay

83% of POLITE TUMOR INC's funders are still giving 3 years after their first grant; 69% give in more than one year at all.

first grant+1y+2y+3y

Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.

Where its funders are

96% of POLITE TUMOR INC's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Of the $26k that is directly attributable, 95% of it comes from funders outside Colorado, across 3 states.

OH
CO
FL

In-state vs out-of-state, by year

’19
’20
’21
’22
’23
Colorado out of state home

Funder states come from each funder’s own filing. $570k arriving through sponsors registered in 6 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.

04Its place in the field

Against its field

POLITE TUMOR INC runs a healthier operating margin than three-quarters of the 13,769 health nonprofits its size.

Operating margin26% · top quartile
Months of reserve24.9mo · top quartile
Revenue growth (annualized)29% · top quartile

this organization peer median middle 50% of peers· 13,769 health nonprofits $100k–$1M, FY2024

Organizations like POLITE TUMOR INC

Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.

In Colorado

Nationally

05Profile & governance

Read directly from this organization’s own Form 990, as neutral context.

Where the money goes

99% of spending goes to programs.

Program 99%Management 1%Fundraising 0%

Governance

3
board members
100%
independent
✓Conflict-of-interest policy–Whistleblower policy–Document retention–Board reviewed the 990–Audited financials

Public support

56%

Share of support from the public (Schedule A) — the basis for its public-charity status.

Screen this organization

A dated, signed PDF of the compliance screen for POLITE TUMOR INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.

A paid feature, included from the $75 plan up. Sign in to download.

Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf

Questions and answers

Who funds POLITE TUMOR INC?
POLITE TUMOR INC (Colorado) receives grants from 13 organizations whose IRS filings report $595,563 to it, the largest being FIDELITY INVESTMENTS CHARITABLE GIFT FUND ($210,200). 9 of them have funded it in more than one year, and 96% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
How many funders does POLITE TUMOR INC have?
IRS filings report 13 organizations giving $595,563 in grants to POLITE TUMOR INC, 9 of which have funded it in more than one year.
Who is the largest funder of POLITE TUMOR INC?
FIDELITY INVESTMENTS CHARITABLE GIFT FUND is the largest funder on record, with $210,200 in grants. The full list of funders is on this page.
How can an organization like POLITE TUMOR INC find more funders?
Start with the funders already giving here, then look at the foundations that back similar organizations in Colorado. The funding by cause and by state pages list the largest funders for a given area and how to approach them.

Play a game about who funds Polite Tumor →

These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 13 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 22, 2026. What this page cannot tell you · view filing